Met-11 of HLA class II DPα1 first domain associated with onchocerciasis

Experimental and Clinical Immunogenetics

Volumn 13, Issue 1, 1996, Pages 12-19

  Meyer, Christian G ^a,b   Schnittger, Leonhard ^a   May, Jürgen ^a  

^a Institute of Tropical Medicine   (Germany)

^b Institute of Tropical Medicine   (Germany)

Author keywords

HLA DPA1; MHC class II; Onchocerciasis; Polymorphism

Indexed keywords

ALANINE; HLA ANTIGEN CLASS 2; METHIONINE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DISEASE SUSCEPTIBILITY; EPITOPES; HAPLOTYPES; HLA-DP ANTIGENS; HUMANS; LINKAGE (GENETICS); METHIONINE; MOLECULAR SEQUENCE DATA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; RISK FACTORS;

ONCHOCERCA VOLVULUS;

EID: 0030037202     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. WHO Expert Committee on Onchocerciasis: Epidemiology of Onchocerciasis. Technical Report Series 752. Geneva, WHO, 1987.
2. Gallin M, Edmonds K, Ellner JJ, Errtmann KD, White AT, Newland HS, Taylor HR, Greene BM: Cell-mediated immune response in human infection with Onchocerca volvulus. J Immunol 1988;140:1999-2007.
3. Büttner DW, von Laer G, Mann weiler E, Büttner M: Clinical, parasitological and serological studies on onchocerciasis in the Yemen Arab Republic. Trop Med Parasitol 1982; 33:201-212.
4. Ward DJ, Nutman TB, Zea-Flores G, Portocarrero C, Lujan A, Ottesen EA: Onchocerciasis and immunity in humans: Enhanced T-cell responsiveness to parasite antigen and putatively immune individuals. J Infect Dis 1988;157:536-543.
5. King CL, Nutman TB: Regulation of the immune response in lymphatic filariasis and onchocerciasis; in Ash C, Gallagher RB (eds): Immunoparasitol Today. Cambridge, Elsevier, 1991, pp A54-58.
6. Heard R: HLA and autoimmune disease; in Lechler R (ed): HLA and Disease. London, Academic Press, 1994, pp 131-144.
7. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM: Common West African HLA antigens are associated with protection from severe malaria. Nature 1991; 352:595-600.
8. de Vries RRP, Ottenhoff THM: Immunogenetics of leprosy; in Hastings RC, Opromolla DVA (eds): Leprosy. Edinburgh, Churchill Livingstone, 1994, pp 113-121.
9. Meyer CG, Gallin M, Erttmann KD, Brattig N, Schnittger L, Gelhaus A, Tannich E, Begovich AB, Erlich HA, Horstmann RD: HLA-D alleles associated with generalized disease, localized disease and putative immunity in Onchocerca volvulus infection. Proc Natl Acad Sci USA 1994;91:7515-7519.
10. Ottesen EA: Immune responsiveness and the pathogenesis of human onchocerciasis. J Infect Dis 1995; 171:659-671.
11. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Plainview, Cold Spring Harbor Laboratory Press, 1989.
12. Saiki RK, Scharf S, Faloona FLA, Mullis KB, Horn GT, Erlich HA, Arnheim N: Enzymatic amplification of β-globulin genomic sequence and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-1354.
13. Mullis KB, Faloona FLA: Specific synthesis of DNA in vitro via polymerase-catalyzed chain reaction. Methods Enzymol 1987;155:335-350.
14. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1994. Tissue Antigens 1994; 44:1-18.
15. Marsh SGE: Nomenclature for factors of the HLA system, update January 1995. Tissue Antigens 1995;45: 220-222.
16. Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-253.
17. Haldane JBS: The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1955;20:309-311.
18. Tsuji K, Aizawa M, Sasazuki T: Proceedings of the 11th Histocompatibility Workshop and Conference held in Yokohama, Japan, 1991. Oxford, Oxford University Press, 1992.
19. Meyer CG, May J, Spauke D, Schnittger L: DPA1*02012: A DPA1*0201-related MHC class II allele in West Africa. Immunogenetics 1994;40:309.
20. Svejgaard A, Ryder LP: HLA and disease associations: Detecting the strongest association. Tissue Antigens 1994;43:18-27.
21. Morling N, Frentz G, Fugger L, Georgsen J, Jakobsen B, Ødum N, Svejgaard A: DNA polymorphism of HLA class II genes in alopecia arreata. Dis Markers 1991;9:35-42.
22. Dong RP, Kimura A, Numano F, Yajima M, Hashimoto Y, Kishi Y, Nishimura Y, Sasazuki T: HLA-DP antigen and Takayasu arteritis. Tissue Antigens 1992;39:106-110.
23. Morling N, Friis J, Fugger L, Georgsen J, Heilmann C, Pedersen FK, Ødum N, Svejgaard A: DNA polymorphism of HLA class II genes in pauciarticular juvenile rheumatoid arthritis. Tissue Antigens 1991; 38:16-23.
24. Mazzola G, Berrino M, Bersanti M, D'Alfonso S, Capello N, Bottaro A, Curtoni ES, Fusco P, Vallati M, Bundino S. Barbera C, Amoroso A: Immunoglobulin and HLA-DP genes contribute to the susceptibility to juvenile dermatitis herpetiformis. Eur J Immunogen 1992;19:129-139.
25. Dong RP, Kimura A, Numano F, Nishimura Y, Sasazuki T: HLA-linked susceptibility and resistance to Takayasu arteritis. Heart Vessels Suppl 1992;7:73-80.
26. Brown JH, Jardetzky TS, Gorga JC, Stem LJ, Urban R, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993;364:33-39.
27. Meyer CG, Kremsner PG: Malaria and onchocerciasis: On HLA and related matters. Parasitol Today, in press.